2024-2029
Preclinical Efficacy & Intermediate Endpoint Biomarkers
| Organization | Principal Investigator |
|---|---|
| Board of Regents of the University of Oklahoma Health Sciences Center |
Chinthalapally V. Rao, Ph.D. George Lynn Cross Professor Phone: 405-271-3224 Email: cv-rao@ouhsc.edu |
| The Institute For Cancer Research Fox Chase Cancer Center |
Margie L. Clapper, Ph.D. Professor, Co-Leader, Cancer Prevention and Control Program Samuel M.V. Hamilton Chair in Cancer Prevention Phone: 215-728-4301 Email: Margie.Clapper@fccc.edu |
| The University of Texas MD Anderson Cancer Center Department of Clinical Cancer Prevention |
Eduardo Vilar-Sanchez, M.D., Ph.D. Department Chair ad interim Department of Clinical Cancer Prevention Division of OVP Cancer Prevention and Population Sciences Phone: 713-563-4743 E-Mail: evilar@mdanderson.org |
| Weill Medical College Of Cornell University | Steven M. Lipkin M.D., Ph.D., F.A.C.M.G. Professor of Medicine and Genetic Medicine Vice Chair for Basic and Translational Research Phone: 646-962-6303 Email stl2012@med.cornell.edu |
Toxicology & Pharmacology
| Organization | Principal Investigators |
|---|---|
| IIT Research Institute | David L. McCormick, Ph.D., DABT President and Director Phone: 312-567-4972 Email: dmccormick@iitri.org |
| The University of Illinois at Chicago | Alexander Lyubimov, M.D., PhD., DABT Scientific Director Phone: 312-996-2123 Email: lyubimov@uic.edu |
CGMP Production of Vaccines/Biologicals
| Organization | Principal Investigators |
|---|---|
| TBD | TBD |